Aldeyra Therapeutics, Inc. ALDX
$0.91
-0.90%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (1 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $5.50
- Implied Upside
- +506.0%
- Price Target Range
- $2.00 – $9.00
- Analysts (12 mo)
- 2
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-30 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Neutral | $2 |
| 2026-09-29 | BTIGThomas Shrader |
Reiterates | Buy | $9 |
| 2026-03-18 | HC Wainwright & Co.Matthew Caufield |
Downgrades | Buy → Neutral | $10 → $2 |
| 2025-11-10 | BTIGThomas Shrader |
Reiterates | Buy | $9 |
| 2025-05-19 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $10 |
| 2025-04-07 | BTIGThomas Shrader |
Maintains | Buy | $11 → $9 |
| 2025-04-04 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $10 |
| 2025-03-03 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $10 |
| 2024-08-09 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $10 |
| 2024-08-02 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $10 |
| 2024-05-06 | OppenheimerFrancois Brisebois |
Reiterates | Outperform | $10 |
| 2024-05-06 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $10 |
| 2024-04-03 | OppenheimerFrancois Brisebois |
Upgrades | Perform → Outperform | $10 |
| 2024-04-02 | HC Wainwright & Co.Matthew Caufield |
Reinstates | Buy | $10 |
| 2023-10-17 | CitigroupYigal Nochomovitz |
Maintains | Buy | $25 → $8 |
| 2023-10-17 | OppenheimerJustin Kim |
Downgrades | Outperform → Perform | — |
| 2023-08-09 | OppenheimerJustin Kim |
Reiterates | Outperform | $14 |
| 2023-06-30 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $15 |
| 2023-06-22 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $15 |
| 2023-06-16 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $15 |
| 2023-06-01 | CitigroupYigal Nochomovitz |
Maintains | Buy | $28 → $25 |
| 2023-05-05 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $15 |
| 2023-03-10 | CitigroupYigal Nochomovitz |
Maintains | Buy | $23 → $28 |
| 2023-03-10 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $15 |
| 2023-03-01 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $15 |
| 2022-11-21 | CitigroupYigal Nochomovitz |
Maintains | Buy | $26 → $23 |
| 2022-06-09 | CitigroupYigal Nochomovitz |
Maintains | Buy | $21 → $26 |
| 2022-04-27 | HC Wainwright & Co.Andrew Fein |
Assumes | Buy | $15 |
| 2021-12-21 | CitigroupYigal Nochomovitz |
Maintains | Buy | $25 → $21 |
| 2021-12-21 | SVB LeerinkMarc Goodman |
Maintains | Outperform | $24 → $15 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $0.91
- Market Cap
- $55.25 million
- 52-Week Range
- $0.86 – $5.93
- Average Volume
- 1.36 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.